Mar 4, 2026 07:30AM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:17AM
Dec 12, 2025 08:32AM
Dec 12, 2025 06:32AM
Dec 12, 2025 06:32AM
Dec 2, 2025 07:57AM Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder
Nov 24, 2025 08:51AM
Nov 24, 2025 08:51AM
Nov 13, 2025 08:54AM
Nov 13, 2025 08:54AM
Nov 6, 2025 04:02PM
Nov 6, 2025 04:02PM
Oct 31, 2025 07:35AM Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy
Jul 30, 2025 08:21AM
Jul 30, 2025 08:18AM
Apr 16, 2025 08:40AM
Apr 16, 2025 08:40AM
Apr 8, 2025 06:55AM
Mar 18, 2025 07:32AM
Mar 18, 2025 07:32AM Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients
Jan 7, 2025 09:28AM
Jan 6, 2025 08:15AM
Jan 6, 2025 08:15AM
Aug 6, 2024 08:57AM
Apr 17, 2024 07:49AM
Apr 17, 2024 07:49AM
Apr 10, 2024 07:17AM Clearmind Medicine (CMND) Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
Apr 10, 2024 07:17AM
Mar 19, 2024 07:55AM
Feb 23, 2024 07:06AM
Feb 23, 2024 07:06AM
Feb 5, 2024 07:51AM
Nov 17, 2022 11:43AM
Nov 14, 2022 07:09PM Clearmind Medicine Announces Pricing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market
Oct 11, 2022 09:00AM
Sep 25, 2022 09:36AM
Sep 22, 2022 08:30AM
Sep 16, 2022 04:30PM
Aug 24, 2022 10:24AM
Aug 24, 2022 07:30AM
Jun 21, 2022 09:00AM Yale’s Department of Psychiatry Chair to Join Clearmind Medicine
Jun 15, 2022 04:52PM
Jun 7, 2022 08:30AM
Jun 7, 2022 08:30AM
Jun 2, 2022 07:48AM
Jun 1, 2022 08:11AM
May 26, 2022 09:30AM
May 24, 2022 08:30AM Clearmind Medicine and SciSparc Collaboration Yields Positive Results for its Psychedelic Combination Treatment
May 19, 2022 08:15AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All